Law360, New York (June 25, 2012, 8:54 PM ET) -- Cardinal Health Inc. and GE Healthcare Inc. said Friday that a California federal court should toss a putative antitrust class action over the cardiac imaging agent market, arguing that their distribution deal targeted by the suit was neither illegal nor anti-competitive.
GE Healthcare and Cardinal, which filed separate motions to dismiss radiopharmacy owner PharmaRx Pharmaceutical Inc.'s lawsuit, also own radiopharmacies, which distribute nuclear drugs used to image the heart, like GE Healthcare's Myoview.
PharmaRx's May 31 amended complaint said the defendants denied competitors effective market access...
Cardinal, GE Ask Judge To Toss Imaging Drug Antitrust Suit
To view the full article, take a free trial now.
